7 September 2022 - The country, with an increasing immunoglobulin usage rate, currently imports about 85% of its immunoglobulin demand for ...
1 April 2022 - Newly available treatments can help Canadians living with haemophilia A better manage their bleeding episodes ...
31 May 2021 - Alpha-1 Canada publicly launched Access for Alphas today, a campaign aimed at raising the awareness of alfa-1 ...
29 June 2020 - The NHS and Sobi UK have come to an agreement that will give people living with ...
21 April 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using andexanet alfa ...
30 April 2019 - PHARMAC has today provided haemophilia patients fully funded access to new innovative treatment options which will ...
8 March 2019 - PHARMAC is pleased to announce changes to funded haemophilia treatments that will result in two new ...
29 January 2019 - PHARMAC is proposing to make changes to the funding of haemophilia treatments from 1 May 2019, ...
27 September 2018 - NICE has published draft guidelines rejecting NHS use of CSL Behring’s Respreeza for treating emphysema in ...
23 July 2018 - PHARMAC invites proposals for the supply of Recombinant Factor VIII, Recombinant Factor IX and bypassing agents (Recombinant ...
29 January 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
11 December 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
22 November 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
20 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
12 October 2016 - HAS has published the agenda for the next scheduled Transparency Commission meeting. ...